-
House panel releases spending bill section on child tax credit, infrastructure financing
The House Ways and Means Committee late Friday released an additional tranche of its portion of Democrats’ $3.5 trillion social spending package, covering a wide range of issues such as the child tax credit, infrastructure financing, clean energy incentives and health care. The release of the 645-page bill section comes after the committee approved several other portions of the bill, including those on paid family leave and expanding Medicare, earlier this week. The committee is scheduled to consider the new section on Tuesday. House Democrats are seeking to move quickly on the $3.5 trillion package, aiming to have all committees … Read more
You May Also Like
Survey Finds Consumers Continue to Struggle to Afford Healthcare Amid Pandemic
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
Medicaid vaccination rate lags as state struggles to reach low-income communities
-
Rethinking Nigeria’s healthcare financing – By: . .
The announcement of a high profile committee by President Muhammadu Buhari on 6 September 2021, to be headed by his Vice President, Prof Yemi Osinbajo to oversee reforms in Nigeria’s health sector is a laudable and timely one. Like most sectors in Nigeria, the health sector is, to put it mildly, in a state of stagnation that, with the existing structure and organisation, is practically impossible to make any headway despite the huge potentials abound in the sector to the economy. Although there are numerous angles to the problem bedevilling Nigeria’s fragile health sector, including the collapse of the primary … Read more
-
CIT Serves as Sole Lead Arranger on Financing for Houston-area Medical Office Building
NEW YORK, Sept. 9, 2021 /PRNewswire/ — CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business served as sole lead arranger on financing for the acquisition of Hedwig Place, a 102,774-square-foot five-story medical office building close to downtown Houston, Texas. The facility is a Class-A medical office building within the affluent Hedwig Village area located about 10 miles west of downtown Houston. Tenants include medical practices in surgery, neurology, ENT and other specialties. The property is being acquired by a joint venture of Virtus Real Estate Capital, an industry-leading investor in medical office buildings … Read more
-
CIT Serves as Sole Lead Arranger on $43 Million Financing for Portfolio of Medical Office Buildings
NEW YORK, Sept. 1, 2021 /PRNewswire/ — CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business served as sole lead arranger on a loan of about $43 million to finance the acquisition of a portfolio of medical office buildings in Florida and Arizona. The portfolio, acquired by Cypress West Partners, consists of 14 medical office buildings encompassing nearly 150,000 square feet of rentable space. Ten of the facilities are located in Arizona and four are in Florida. “This portfolio consists of modern, well-designed and efficient facilities in attractive locations to support the medical needs … Read more
-
Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genome Medical, the leading nationwide genomic care delivery company, today announced that it will acquire GeneMatters, a telehealth genetic counseling and software solutions company. Simultaneously, the company announced the closing of a $60 million Series C financing to accelerate commercial traction and advance its mission of transforming health care for all through genomic medicine. These strategic initiatives solidify its position as the preeminent technology-enabled provider of genetic health services and genomic insights. “The addition of GeneMatters, along with our Series C financing, propels us into the next phase of commercial growth and … Read more
-
ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million
ADCT sells capped royalty interest on ZYNLONTATM and Cami for $225 million upon closing with an additional $100 million in potential near-term milestone payments Royalty of 7% terminates upon payment of 2.25x to 2.50x the purchase price Proceeds to be used for continued development and commercialization of ZYNLONTATM and Cami LAUSANNE, Switzerland, August 26, 2021–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company leading the development of novel antibody drug conjugates (ADCs) to treat hematological malignancies and solid tumors, today announced it had entered into a royalty purchase agreement with HealthCare Royalty Partners (HealthCare Royalty).… Read more
